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METHODS
• Prenatal diagnosis comprises a variety of techniques aimed to determine the health and condition of the embryo or foetus.
• It has been used in clinical practice for more than 40 years, but it was during the last two decades that advances in non-invasive tests such as
ultrasound technology, and invasive techniques such as amniocentesis or chorionic villus sampling for pregnancies at increased risk for
chromosomal anomalies or genetic diseases have started to be used more frequently.
• The Portuguese prenatal surveillance programme advise ultrasound screenings, in the first trimester of pregnancy in combination with the
screening test, and between 20 - 22 weeks of pregnancy. Other tests are offered in pregnancies with an increased risk (1).
The aim of this study is to assess the evolution of prenatal diagnosis in the detection of congenital anomalies (CA).
OBJECTIVE
A cross sectional study was implemented using data
collected between 1997 and 2016 by the Portuguese
registry of CA (RENAC).
RENAC (2) is a population based registry, full member of
EUROCAT since 1996 and follows the European registry
guidelines (3).
For this study a case was defined with at least one CA
potentially detectible by prenatal diagnosis (Table 1).
Descriptive analysis was performed using absolute and
relative frequencies and bivariate analysis was conducted
using chi-square statistics.
Table 1. List of congenital anomalies included in the study
Nervous system: Anencephalus and similar; Hydrocephalus; Spina Bifida; Holoprosencephaly.
Severe congenital heart defects: Transposition of great vessels; Coarctation of aorta; Tetralogy of Fallot;
Hypoplastic left heart; Single ventricle; Common arterial truncus; Tricuspid atresia and stenosis; Ebstein's
anomaly; Aortic valve atresia/stenosis; Pulmonary valve atresia/stenosis.
Non severe congenital heart defects: Ventricular septal defect; Atrial septal defect.
Digestive system: Diaphragmatic hernia
Abdominal wall defects: Gastroschisis; Omphalocele.
Urinary: Bilateral renal agenesis; Renal dysplasia; Congenital hydronephrosis.
Limb: Limb reduction defects; Club foot - talipes equinovarus.
Oro-facial clefts: Cleft lip; Cleft palate with or without cleft lip.
Chromosomal: Trisomy 21; Trisomy 18; Trisomy 13.
RESULTS
The analysis included 13566 cases reported with at least
one of the studied CA.
There was an statistically significant increase in the
detection of CA through prenatal diagnosis compared to
detection at birth or after birth (Figure 1, Table 2,
p<0.001).
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Table 2. Evolution of prenatal diagnosis, gestational age at discovery and diagnosis test performed from 1997 
to 2016
1997-1999 2000-2008 2009-2016
n % n % n % p-value**
Prenatal diagnosis No 852 47.9 2980 49.1 2116 37.1 <0.001
Yes 926 52.1 3096 50.9 3583 62.9
GA* at discovery <14 week 39 7.9 249 9.9 847 28.9 <0.001
14-23 week 285 58.2 1192 47.3 1380 47.2
>=24 week 166 33.9 1081 42.9 697 23.8
Prenatal tests Ultrasound 486 27.2 2,78 45.8 3,168 55.6 <0.001
Invasive tests 338 18.9 246 4.05 173 3.03
Other tests 15 0.84 33 0.54 256 4.50
No prenatal 
tests 950 53.1 3017 49.7 2104 36.9
*GA - gestational age; **p-value of chi-square 
test for comparison of independent variables
In addition, there was an increase of cases detected during pregnancy from 52.1% 
(1997-1999) to 62.9% (2009-2016) especially in cases detected before 14 weeks (7.9% 
to 28.9%). 
Comparing the same periods of time the results also show a range of ultrasound 
screening from 27% to 55.8% and a decrease in invasive tests from 18.9% to 3%. This 
tendency was statistically significant (p<0.001).
The data show a positive effect on the percentage of cases with CA detected during 
pregnancy. These results show the importance of extending prenatal tests to the all 
pregnant women and not only to those with specific risk gestations. 
CONCLUSIONS
Figure 1. Time of diagnosis of congenital anomalies from 1997 to 2016
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